CD44 and glioblastoma: To determine the clinical relevance, we reanalyzed the public TCGA GBM database and found that CD44 was highly expressed in the mesenchymal type of GBM patients compared to other types of GBM, which further supported that the expression level of CD44 was positively associated with the mesenchymal phenotype of GBM (Figure 5A).